Zurcher Kantonalbank (Zurich Cantonalbank) - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 96 filers reported holding SPERO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$4,000
+300.0%
1,9500.0%0.00%
Q2 2022$1,000
-94.1%
1,9500.0%0.00%
Q1 2022$17,000
-67.3%
1,950
-39.6%
0.00%
Q4 2021$52,000
-20.0%
3,226
-9.2%
0.00%
Q3 2021$65,000
+35.4%
3,553
+2.7%
0.00%
Q2 2021$48,000
-2.0%
3,459
+5.0%
0.00%
Q1 2021$49,0003,2950.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,376,968$14,596,00024.02%
Aquilo Capital Management, LLC 1,154,356$12,236,0008.62%
VHCP Management II, LLC 474,015$5,025,0001.92%
AWM Investment Company, Inc. 598,315$6,342,0001.35%
BVF INC/IL 939,704$9,961,0001.05%
Novo Holdings A/S 465,983$4,939,0000.85%
Alphabet Inc. 1,112,473$11,792,0000.35%
Artal Group S.A. 540,000$5,724,0000.23%
Rock Springs Capital Management LP 525,000$5,565,0000.22%
DAFNA Capital Management LLC 39,395$418,0000.16%
View complete list of SPERO THERAPEUTICS INC shareholders